StockrabitBrowse analysts
Analyst questions

Arjun Sindhwani

Goldman Sachs
COHANCE

Cohance Lifesciences Limited

All company calls
Cohance Lifesciences Limited CC-Sep24.pdf
12 Nov 2024
Open call
  1. Probably, this question has already been answered in the last set of questions. I just want to understand, on the Spec Chem, like just from the presentation, both the zero revenue is booked for this quarter for Spec Chem? And like just the second part of the question is that you mentioned like the recovery you started seeing in the segment.

    Read in transcript
  2. But the majority of growth is expected in FY26 is what then is probably that is the expectation from management because then H2 is when the sort of orders come in and it is sort of like SKU towards the end of the year then?

    Read in transcript